Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: DaShenLin Pharmaceutical Group Co., Ltd.

Market Cap 19B 2.81B 2.42B 2.23B 2.09B 3.92B 265B 3.96B 26.32B 10.28B 130B 10.53B 10.31B 449B P/E Ratio 2026 *
12.8x
P/E Ratio 2027 * 11.2x
Enterprise Value 15.48B 2.29B 1.97B 1.81B 1.7B 3.2B 216B 3.23B 21.44B 8.38B 106B 8.58B 8.4B 366B EV / Sales 2026 *
0.52x
EV / Sales 2027 * 0.45x
Free-Float
34.77%
Yield 2026 *
5.29%
Yield 2027 * 5.6%
1 day-2.91%
1 week+5.64%
Current month+1.09%
1 month-11.32%
3 months-12.53%
6 months-3.86%
Current year-5.33%
1 week 15.68
Extreme 15.68
17.4
1 month 15.34
Extreme 15.34
18.82
Current year 15.34
Extreme 15.34
21.78
1 year 15.34
Extreme 15.34
21.78
3 years 11.92
Extreme 11.92
30.22
5 years 11.92
Extreme 11.92
39.47
10 years 11
Extreme 11.0028
61.63
Manager TitleAgeSince
Chief Executive Officer 44 27/02/2019
Director of Finance/CFO 44 09/05/2018
Human Resources Officer 48 -
Director TitleAgeSince
Director/Board Member 63 07/08/2016
Chairman 59 15/07/2013
Chairman 48 27/05/2015
Change 5-day change 1-year change 3-year change Capi.($)
-2.91%+5.64%+2.52%-43.36% 2.81B
-2.97%-0.97%-13.53%-32.81% 15.39B
-2.83%-0.87%-28.09%-33.66% 7.28B
-0.19%-1.08%-18.09%-14.93% 5.74B
-3.86%+2.05%-16.43%-36.23% 3.75B
-0.57%-1.92%-35.45%-12.93% 3.38B
+0.73%+0.58%-24.25%-44.67% 3.3B
-0.49%+5.85%+117.78% - 2.72B
+1.09%0.00%-21.68%-2.89% 2.62B
+0.06%+2.47%+7.12%+39.14% 1.77B
Average -1.20%+2.03%-3.01%-20.26% 4.88B
Weighted average by Cap. -1.81%+2.06%-10.16%-26.56%

Financials

2026 *2027 *
Net sales 29.97B 4.43B 3.82B 3.51B 3.3B 6.19B 418B 6.25B 41.52B 16.22B 205B 16.62B 16.27B 709B 33.01B 4.88B 4.2B 3.87B 3.63B 6.82B 461B 6.89B 45.74B 17.87B 226B 18.3B 17.92B 781B
Net income 1.48B 219M 189M 174M 163M 307M 20.73B 310M 2.06B 804M 10.15B 823M 806M 35.13B 1.7B 252M 217M 200M 187M 352M 23.77B 355M 2.36B 921M 11.64B 944M 924M 40.28B
Net Debt -3.52B -520M -448M -412M -387M -727M -49.14B -734M -4.88B -1.9B -24.06B -1.95B -1.91B -83.27B -4.01B -592M -511M -470M -441M -828M -55.99B -836M -5.56B -2.17B -27.42B -2.22B -2.18B -94.88B
Logo DaShenLin Pharmaceutical Group Co., Ltd.
DaShenLin Pharmaceutical Group Co Ltd is a China-based company principally engaged in the pharmaceutical retailing business. The Company is mainly engaged in the chain retail business of Chinese and Western patent medicines, ginseng and antler tonic medicinal materials and Chinese herbal medicine slices, health products, medical devices and other commodities. The Company is also involved in the production of Chinese herbal medicine slices, ginseng and antler tonic, health products, Chinese and Western patent medicines. The Company's brands include Dong Zi Yun Xuan, Cocoking, Nobe Huale, Dongteng Ejiao, and Fuer. The Company mainly conducts business within domestic market.
Employees
41,141
Date Price Change Volume
15/06/26 16.68 ¥ -2.91% 7,860,601
12/06/26 17.18 ¥ +4.44% 8,491,177
11/06/26 16.45 ¥ 0.00% 5,182,573
10/06/26 16.45 ¥ +3.85% 6,503,179
09/06/26 15.84 ¥ +0.32% 5,742,741
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
16.68CNY
Average target price
24.49CNY
Spread / Average Target
+46.81%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 603233 Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!